Low- vs high-dose cyclophosphamide in lupus nephritis

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1359, 2002-01, pp. : 13-13

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Low-dose fludarabine plus cyclophosphamide is effective in patients with proliferative lupus nephritis, but is associated with considerable adverse outcomes

Inpharma, Vol. 1, Iss. 1600, 2007-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

Ezetimibe + low-dose atorvastatin vs high-dose atorvastatin

Inpharma, Vol. 1, Iss. 1580, 2007-01 ,pp. : 20-20

Adis International

Access to resources Recommend Favorite

MMF surpasses cyclophosphamide in lupus nephritis

Inpharma, Vol. 1, Iss. 1516, 2005-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

High-dose cyclophosphamide promising in severe aplastic anaemia

Inpharma, Vol. 1, Iss. 1312, 2001-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

High-dose torasemide vs furosemide for refractory CHF

Inpharma, Vol. 1, Iss. 1486, 2005-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite